The EU Regulation Quietly Reshaping Every Sunscreen Aisle in Ireland

I was supposed to be writing about glitter. The kind that ends up on the kitchen floor in November, the kind your daughter brings home from a school art project, the kind that has been quietly banned in cosmetics across Europe since October 2023. The piece I had pitched was a thousand-word service article on the new microplastics rules and what they meant for everyday products in Ireland. Routine wellness journalism. The kind of piece I had written a hundred times.

The piece I ended up writing took six months. It is not about glitter. It is about every bottle of sunscreen on every shelf in every Boots Ireland between Dún Laoghaire and Galway, and the regulation that is quietly going to change all of them before 2027 — and the small Bulgarian family that built the version of sun protection the rest of the European industry will be selling by then.

The trigger was a phone call to a cosmetic chemist in Antwerp on a Tuesday night last October. I had emailed her for a five-minute fact-check on a single line in the original piece. She gave me the line. Then, almost as an afterthought, she said something I have not been able to stop thinking about since.

You're writing the wrong piece, Charlotte. The glitter ban is the small story. The big story is what happens to every bottle of SPF on Boots Ireland between now and 2027.

I cancelled the piece I had been writing the next morning.

Six months later, I have an article I have not been able to get published anywhere. No women's magazine in Ireland wants to be the first to break a regulatory story about the cosmetic industry. The trade press has covered fragments of it. The consumer press has not. So this is running here, on a small editorial site, because I think Irish women have a right to know what is happening to the products on their bathroom shelves before the products themselves quietly disappear and get replaced.

What I want to tell you, briefly, before you read on. This piece is not anti-sunscreen. The dermatology consensus on UV protection is correct, important, and has saved lives. UV remains the leading preventable cause of skin cancer. Nothing in this article contradicts any of that. What this is, is a story about the product category that is about to be quietly transformed by regulation most consumers have not been told about — and about a single small brand that has been ahead of the change for six years, by accident, because they were never on the same track to begin with.

The Glitter Ban Was the Tip of the Iceberg

The mainstream story is the one you have probably read. EU Regulation 2023/2055, which entered into force in October 2023, is the world's most significant restriction on intentionally added microplastics in consumer products. The press covered it through the angle most accessible to readers — the glitter ban. The body wash microbeads. The cosmetic exfoliants. The Irish Times ran a feature on it in November 2023. The Sunday Business Post covered the trade implications. Most of the reporting was accurate, as far as it went.

What the mainstream reporting missed is the regulation's broader scope. The definition of "intentionally added microplastics" extends well past glitter. It includes synthetic polymer particles below 5mm used as carriers, suspending agents, film-formers, and texture modifiers. These are present, in some form, in most modern liquid and cream cosmetics — including, particularly, the daily-wear sunscreens that line the shelves in every Boots Ireland, every Dunnes, every Brown Thomas Beauty Hall.

The regulation's phasing is generous. Different cosmetic categories have different transition timelines. Leave-on cosmetics like sunscreen have a longer compliance window than rinse-off products. Some categories run into 2029 or beyond. But the compliance pressure is already driving reformulation across the European cosmetic industry, and most of the major sunscreen brands sold in Ireland have parallel reformulation programmes already running in the background. The retail consumer just has not been told.

The Health Products Regulatory Authority — the HPRA, Ireland's cosmetics regulator — follows the EU framework directly. Ireland, unlike Britain after Brexit, remains within the unified European cosmetic regulatory environment. The reformulation pressure that applies to Continental Europe applies equally here. The Irish woman buying her usual sunscreen in Brown Thomas this month is buying a product whose formulation is on a published regulatory transition. She has not been informed. She will not be informed. The reformulated product will arrive on the shelf in 2026 or 2027 and will be marketed as if it has always been this way.

I went looking for someone in cosmetics willing to explain what was happening behind the scenes. The first three calls did not return. The fourth did. She wanted to be quoted on background only — the company she works for is one of the brands that will need to reformulate.

The Cosmetic Chemist on the Phone

Her name does not matter for the purposes of this piece. What matters is that she has spent fifteen years at a major European sunscreen brand, that she was speaking to me from her kitchen table in Antwerp, and that she was clear-eyed about what is happening inside her industry in a way most public-facing brand spokespeople are not allowed to be.

It was nine in the evening Irish time when we spoke. Her teenage children were watching television in the next room. I could hear the low murmur of Flemish-language news through the line. She had agreed to talk to me on the strict condition of anonymity, and I have honoured that condition by leaving her surname, her employer, and the specific products her team is reformulating out of this piece.

What she explained took the better part of an hour. The version that follows is condensed.

Most petrochemical UV filter formulations require a polymer suspension matrix to keep the active ingredient evenly distributed throughout the lotion. That polymer is typically what allows a sunscreen to feel "non-greasy," "absorbent," or "long-wear." It is also, in many cases, what makes the product fall under the EU's microplastics scope. A modern daily-wear SPF is, mechanically, a cocktail of UV-active compounds suspended in a polymer carrier system that has been engineered, over thirty years, to deliver a specific cosmetic experience to the consumer.

The industry has been aware of the regulatory pressure since 2019. Major brands have been quietly running parallel reformulation programmes since then. The R&D budgets involved run, in some cases, into the tens of millions of euro. The reformulation timeline for a major-brand sunscreen takes between eighteen and thirty-six months — sometimes longer — and involves replacing core polymer chemistry with alternatives that, at least at the current state of the art, perform less well on consumer testing for texture, finish, and what the industry calls "elegance."

Then she said the thing that ended up shaping the rest of the piece.

I asked her, directly, whether there was anything currently on the market that was already compliant with where the regulation was heading.

She thought about it for a long moment.

"Almost nothing in mainstream retail," she said. "The big brands won't be ready until 2026 at the earliest. The brands that are already compliant are small, mostly continental, and mostly working from biological actives that don't require polymer suspension at all. There's a Bulgarian one I've been watching with professional curiosity for about two years. They didn't set out to be ahead of the regulation. They just chose a formulation pathway that was always outside the scope."

I wrote down the brand name. I rang off shortly after. I sat at the kitchen table in my flat in Ranelagh with the notebook open in front of me and my coffee going cold and I knew, in the way you know when a piece has just changed shape underneath you, that the article I had been planning to write was no longer the article I was going to write.

Sent by Margaret, 54 · Wicklow

"I read this article on a Tuesday night with the kitchen lamp on and the dog asleep at my feet. I'd been buying the same sunscreen for ten years. It hadn't occurred to me to ask what was actually in it."

The Two Tracks the Industry Has Been Running

What the chemist had described, when I sat with my notes for two days afterwards and worked out what it meant, was a cosmetic industry running on two parallel tracks since roughly 2019.

The public-facing track is the one consumers see. New launches. Marketing campaigns. "Innovation" announcements. The new SPF for spring. The reformulated mineral version. The brand ambassador on the bus shelter on Camden Street.

The behind-the-scenes track is reformulation pressure, supply chain reorganisation, and the slow, expensive work of replacing polymer chemistry with alternatives. It is happening in laboratories in Lyon, in Antwerp, in Hamburg, in Milan. It involves chemists who have been doing this work for two decades and who, when you ring them on a Tuesday night, will tell you that the products they have been working on are not the products you will be buying in 2027.

The two tracks rarely cross in public. Brands do not announce that they are reformulating because of a regulation. They wait until the new product is ready, then launch it as an "improvement," and discontinue the old one without explanation. The marketing language being drafted for these transitions is already in use across the trade press — phrases like "enhanced formulation," "updated science," "next-generation protection." None of which is wrong, exactly. But none of which tells the consumer the truth.

This is, I want to be clear, not a story about brands acting in bad faith. The reformulation challenge is real. The products being phased out are not unsafe to use — the regulation is environmental, not toxicological. The microplastic compounds in question do not cause acute harm to the woman applying them. They harm the marine and freshwater environment they wash off into. Most cosmetic chemists I spoke to during the six months of reporting this piece were genuinely supportive of the regulation. The frustration was not with the rule. The frustration was with the timeline and the cost.

What the chemist on the phone had understood, that I had not understood until she said it, is that the consumer is the one this transition is being kept quiet from. The trade press has covered it. The dermatology profession knows. The HPRA is following it carefully. The Irish woman buying SPF at Brown Thomas does not know. She has not been told. The reformulated bottle she will buy in 2027 will look like the bottle she has been buying for a decade. It will not be the same product.

I sat with this question for two weeks before I started looking for the next interview. I was not sure, at this point, what the third act of the piece was. The mechanism was clear. The professional silos were clear. The regulation was real. But the alternative the chemist had alluded to — the small Bulgarian brand already past the change — was the part I had not yet investigated.

That is the part the rest of this piece is about.

Does Any of This Sound Familiar?

Before I tell you what I found, I want to ask you something. Have any of these started showing up in your bathroom routine in the last two or three years?

If you ticked even two of those, you are not behind the curve. You are ahead of it. The reformulation is going to catch most of the high street unprepared. There is a small group of women in Ireland — perhaps a few thousand — who have already moved past the change. The rest of the country will get there in 2026 or 2027, when the brands they have been trusting quietly switch the formulations in their bottles.

The Family in a Rose Valley Who Got Ahead by Accident

Two days after the call with the cosmetic chemist, I had a video meeting scheduled with the family that runs the brand she had named. Four in the afternoon, Irish time. I sat in my flat in Ranelagh with a notebook open and a coffee in front of me and I waited for the call to connect.

The brand is called Gentle & Rose. The product, in question, is called Antarctic Sun Defence.

What I learned over the next ninety minutes — and what I confirmed afterwards through three independent sources, including the cosmetic chemist who had pointed me to them — is the following.

Gentle & Rose is not a corporation. It is a family brand, three generations old, based in a town near the Kazanlak Valley in central Bulgaria. The Kazanlak Valley supplies, by most estimates, around 85% of the world's rose oil — the cold-pressed damascena variety that goes into the perfumery houses of Grasse and the luxury skincare counters of Paris, Milan, and London. The family has been adjacent to this trade for two generations. The current generation — two siblings, both in their thirties when the project started — pivoted the family's business from rose oil supply into formulated direct-to-consumer skincare around 2017.

The activeCold-water polar algae cultivated in partnership with a Sofia biotech lab. The same family of organisms studied in marine biology for their extreme UV resilience.

What they wanted to build, when they started Antarctic Sun Defence's development in 2019, was a sun protection product their own family would use. The brief was simple. Protective, but not greasy. Stable, but not chemical-heavy. Made from ingredients they could trace back to the field, the lab, or the ocean. The brief was not built around the existing cosmetic industry's assumptions. They were not trying to compete with the major brands. They were trying to make the product they themselves would want to use.

This matters, because the formulation pathway they chose — cellular UV defence compounds cultivated from cold-water polar algae, suspended in a base of damascena rose oil and low-molecular hyaluronic acid, with a small portfolio of plant-derived emulsifiers — happens not to require polymer suspension. The active itself is stable in a simple lipid base. The carrier matrix the rest of the industry depends on is not in the formulation at any point.

They did not know about the EU microplastics regulation when they were doing this work. The regulation was published in late 2023, four years into Antarctic Sun Defence's development. By the time the family found out about it, they had already done the work. The product they had been formulating was, accidentally, what the rest of the industry was about to be forced down a long road of reformulation to achieve.

We didn't know about the regulation when we were building the product. By the time we found out, we realised we'd already done the work. It was a strange feeling. We'd spent five years working on a formulation pathway that the rest of the industry was about to be forced down. We'd been ahead by accident.

What they had built, by ignoring the existing industry's chemistry, was the version of sun protection the existing industry was about to need. By the time the major brands finished their reformulation programmes in 2026 or 2027, the Bulgarian family in the Kazanlak Valley would have had a six-year head start.

Every batch is manufactured under EU cosmetics regulation EC 1223/2009 — the same regulatory framework that governs every product on every Boots Ireland shelf, every Brown Thomas counter, every pharmacy in this country. Independently safety-assessed. Same standards as the rest of European cosmetics. Different priorities entirely.

Sent by Aoife, 47 · Dublin

"I stood in the sunscreen aisle in Boots on Grafton Street last Tuesday and read the back of every bottle on the shelf. I'd never done that before. I think a lot of women in Ireland are about to start doing it."

What's Actually In the Bottle

The product on the bathroom shelf is, by the standards of most modern cosmetic formulations, almost embarrassingly simple. Three actives. A small portfolio of plant-derived support compounds. No polymer carrier. No film-forming microplastic. No PFAS-class water-resistance enhancers. The ingredient list runs to a single column on the back of the bottle.

The productAntarctic Sun Defence. Cold-water polar algae extract. Cold-pressed damascena rose oil. Low-molecular hyaluronic acid.

Mycosporine-Like Amino Acids — the cellular UV defence active.

The compound class the chemist on the phone had been telling me about. Cultivated from cold-water polar algae through a Sofia biotech partnership. Studied in marine biology since the 1970s. Sustainably commercialised only in the last decade. They work through cellular UV defence rather than surface UVB blocking — they absorb UV damage at the cellular level after photons have entered the cell, rather than reflecting or absorbing them at the surface. Critically for the purposes of this piece, they do not require polymer suspension to remain stable in formulation. The active itself is water-soluble and stable in a simple lipid base.

Cold-pressed damascena rose oil — the family active.

The same active that runs through the rest of the Gentle & Rose line, sourced from the Kazanlak Valley harvests the family has been adjacent to for three generations. Barrier protection. Lipid layer support. In this formulation, it does the structural work that the polymer carrier would otherwise do — keeping the active suspended, the texture stable, the application even.

Low-molecular hyaluronic acid — the hydration layer.

Deep dermal hydration that penetrates rather than evaporating off the surface. Most daily SPF products dehydrate the skin over the course of a day. This one is engineered to do the opposite.

The Price

I had been so focused on the formulation that I forgot to look up the price until the bottle arrived at my flat in Ranelagh. By the time I did, I had mentally prepared myself. Mycosporine-like amino acids are expensive to cultivate. Comparable European products with this kind of active formulation sit at €70 to €90 in Brown Thomas Beauty Hall and the equivalent counters in Paris and Milan.

I scrolled to the order page. And I said it out loud, alone in the kitchen:

That can't be right.

€39.

I emailed the founders that night and asked them how it was possible.

The answer was the simplest thing I had heard in twelve years of covering this industry:

We don't spend money on anything except what goes inside the bottle. No celebrity. No campaign. No Brown Thomas counter. No distributor taking 40%. The formula is the product. The price is the cost of the formula.

For context: a year of Antarctic Sun Defence is roughly €312 if you replace it monthly. Most women I spoke to during this piece are getting six to eight weeks per bottle, which puts the annual cost closer to €240. The mid-range Boots Ireland daily SPF sits between €18 and €42 per bottle, with the premium Brown Thomas options running between €60 and €120. Antarctic Sun Defence sits at the top end of mainstream pricing and well below premium pricing — which is, structurally, where it belongs.

The texture is light. Sits cleanly under makeup. No white cast. No pilling. No greasy film. Less than thirty seconds to apply. Once in the morning. That is the entire routine.

Three Irish Women on the Reformulation Front Line

A

Aoife, 47

Solicitor · Ballsbridge, Dublin

Aoife is the clean-beauty veteran. She has been gradually reformulating her bathroom shelf for the better part of five years — replacing one product at a time, reading ingredient lists, working through the small frustrations of finding alternatives that actually feel as good as the products she was replacing. Sunscreen had been the last item on the list. She had not worked out what to do about it.

She came across the original article about EU 2023/2055 in The Irish Times in late 2024. The piece focused on glitter. Aoife, by virtue of her job — environmental and regulatory law — read the underlying regulation properly. She realised the scope was broader than the article had suggested. She started looking, quietly, for sunscreens that fell outside it.

She found Antarctic Sun Defence through a colleague at a regulatory affairs conference in Brussels in early 2025.

"I almost didn't order it," she told me. "The price felt suspiciously low. I had spent the previous two years working through €60 and €70 European mineral sunscreens that all left a white cast or pilled under foundation. I assumed €39 meant something was being skipped. I rang the founders directly to ask what they were leaving out. Their answer was: 'the marketing budget.' I ordered a bottle the same afternoon."

Six weeks in, a colleague at her firm in the IFSC stopped her by the lift and said, "Aoife, you look different in the photographs from this year's company event compared to last year's. What have you done?"

She told me: "I had not done anything dramatic. I had switched one product. The thing I had switched was the only product I had been quietly worrying about for two years. The relief of having worked it out was visible on my face before I had thought to put it into words."

Sent by Aoife, 47 · Dublin

"Three months in. The only thing on my bathroom shelf that's changed. Five components on the back of the bottle. After two years of trying to find a sunscreen I'd actually use every day, the answer was the simplest thing I'd seen in any pharmacy."

N

Niamh, 51

Hospital Pharmacist · Galway

Niamh is the professional skeptic. She reads ingredient lists for a living. She has spent twenty-six years working in hospital pharmacy on the west coast of Ireland, and her professional posture toward consumer cosmetics is, in her own words, "tired."

She came to Antarctic Sun Defence through a colleague at a regulatory affairs CPD event in Dublin in early 2025. The colleague had been tracking the EU microplastics rollout from the cosmetics side. They had been comparing notes over coffee. Niamh, who had been increasingly uncomfortable with the formulation complexity of the daily-wear sunscreens she had been recommending to patients, had asked the colleague what she was using personally.

"She told me about a Bulgarian product with five components on the back of the bottle. I asked her if it was a joke. She said it wasn't. I went home that night and looked it up."

Niamh has been on Antarctic Sun Defence for nine months. Her teenage daughter — who, she said, had been pestering her for two years to "use cleaner products" without quite being able to articulate what that meant — finally walked into the bathroom one morning, looked at the bottle on the counter, read the back of it, and said: "Mam. You're doing the thing you've been telling me to do."

Niamh told me: "I had spent fifteen years reading the back of cosmetic bottles for a job. The first time I read this one, I thought there had been a printing error. There were five components on the back of the bottle. That was the entire formulation. After fifteen years of reading the back of cosmetic bottles, the simplicity was almost suspicious. And then I realised — that's the point. Five things that work. Nothing else."

Sent by Niamh, 51 · Galway

"First proper walk on the beach in Salthill in years where I wasn't worried about reapplying every two hours. The active in this product holds across the day. I had forgotten what that felt like."

Sent by Eileen, 52 · Limerick

"Saturday morning at my kitchen table in Castletroy. Two months on this product. My husband took the photo without telling me. He said I'd been smiling more in the mornings. I had not noticed."

What to Expect in the Reformulation Years

This piece has been about a regulatory transition more than a product. Here is what to expect from the next two years if you are watching the sunscreen aisle in Boots Ireland.

You don't have to wait for the reformulation. You can move ahead of it now.

A Few Things You Might Be Wondering

Why It's Hard to Get

I have to be upfront about something, because it will affect whether you can actually buy this.

Antarctic Sun Defence is not in Brown Thomas. Not in Arnotts. Not on Boots Ireland. There are no Irish stockists, no influencer programmes, no department store counters.

The reason is the active. Mycosporine-like amino acid compounds cannot be synthesised in a conventional cosmetics lab. They have to be cultivated through partnered biotech facilities — in this case, a small lab in Sofia working in collaboration with the Gentle & Rose family operation. The cultivation cycle is constrained. The output is finite. There is no shortcut.

Current capacity: approximately 600 bottles per month for the Irish market within the broader European allocation. When they're gone, they're gone until the next production cycle.

This isn't manufactured urgency. It's biotech infrastructure constraint.

I confirmed directly with the family: fewer than 60 bottles remain from the current Irish allocation.

Two Mornings

In one version, you close this page. You go back to your bathroom shelf. The SPF you have been using since 2014. You apply it tomorrow. You apply it next year. In 2026 or 2027, the bottle on your shelf will quietly be replaced by a "new and improved" version. The product you actually liked will disappear without explanation. You will switch to whatever the brand reformulated to. It will be fine. It just will not be the product you trusted.

In the other version, you move ahead of the change. You order the bottle that is already where the rest of the industry is heading. You give it three months. Your skin gets calmer. Your sunscreen sits cleanly under makeup. By 2027, when the high-street is mid-reformulation chaos, you will have been on the same product for two years. You will have stopped paying attention to the news cycle entirely. Your bathroom shelf will have been quiet for eighteen months.

And sometime around month three, someone says something. Something small. At a parent-teacher meeting in Cork. At Sunday lunch in Rathmines. At a wedding you'd been quietly dreading because you knew there would be photographs.

And for the first time in a long time, when you look in the mirror, you actually agree with them.

The microplastics regulation is going to reshape the sunscreen aisle in Ireland over the next two years. You can either be reshaped along with it, or you can sit out the disruption entirely.